Ishihara Chemical Co., Ltd. (4462.T)
Kobe, JP
Established in Kobe, Japan, in 1900, Ishihara Chemical Co., Ltd. functions as a global producer and distributor of a diverse array of chemical products. The company develops plating chemicals essential for the fabrication of electronic components integrated into household devices, communication equipment, and office machinery. Additionally, they provide advanced analytical instruments for surface treatment solutions vital to the production of printed circuit boards and display panels, which include those for flat-screen televisions, mobile phones, and gaming consoles; this offering is complemented by necessary reagents and post-sale technical support. Their product portfolio also features electronic materials like submicron nickel powders, fundamental for manufacturing capacitor electrodes. Ishihara Chemical is a specialist in ceramic solutions, offering both machinable and engineering ceramics, alongside precision ceramic parts designed for various components and fixtures within semiconductor and LCD manufacturing equipment. Under the Unicon brand, the company manufactures an extensive range of automotive care chemicals. This includes car wash detergents for gas stations, maintenance products for auto inspection and repair centers, compounds and repair chemicals for vehicle body painting facilities, anti-spatter agents for welding, and consumer-grade items for retail. Furthermore, Ishihara Chemical distributes a wide selection of inorganic compounds and fine chemicals, such as acids, alkalis, and catalysts, to various sectors including the steel, chemical, and heavy industries, as well as government entities.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.79% | -15.00% | -8.73% | -12.05% | +11.48% | +8.94% | +24.72% | +48.60% | +119.85% | +272.35% | +170.78% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-0.8% Q1'26: +5.9% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%+25.3% ★ Q1'26: +95.0% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%+10.2% Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+16.4% ★ Q1'26: +20.0% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+22.6% ★ Q1'26: +28.9% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-3.9% ★ Q1'26: +0.1% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×0.00× ★ Q1'26: 0.00× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
Mar 2024 actual |
|---|---|---|---|---|---|---|---|
| Revenue |
14.96B
est: 15.00B (-0.2%)
|
15.76B
est: 15.70B (+0.4%)
|
16.79B
est: 17.00B (-1.3%)
|
16.97B
est: 18.00B (-5.7%)
|
19.04B
est: 18.50B (+2.9%)
|
20.35B
est: 20.60B (-1.2%)
|
20.71B
est: 22.80B (-9.2%)
|
| EBITDA |
1.58B
est: 2.37B (-33.5%)
|
1.91B
est: 2.49B (-23.2%)
|
1.95B
est: 2.69B (-27.4%)
|
2.62B
est: 2.85B (-8.0%)
|
3.29B
est: 2.93B (+12.5%)
|
2.96B
est: 3.26B (-9.3%)
|
3.14B
est: 3.86B (-18.7%)
|
| EBIT |
1.20B
est: 1.98B (-39.1%)
|
1.57B
est: 2.07B (-24.2%)
|
1.50B
est: 2.24B (-33.1%)
|
2.08B
est: 2.37B (-12.5%)
|
2.80B
est: 2.44B (+14.8%)
|
2.42B
est: 2.72B (-11.1%)
|
2.62B
est: 3.55B (-26.2%)
|
| Net Income |
898.01M
est: 825.24M (+8.8%)
|
1.14B
est: 958.87M (+18.4%)
|
1.05B
est: 1.03B (+2.0%)
|
1.50B
est: 1.12B (+34.8%)
|
2.05B
est: 1.18B (+74.1%)
|
1.68B
est: 1.96B (-14.0%)
|
1.91B
est: 2.05B (-7.0%)
|
| SGA |
2.55B
est: 2.44B (+4.7%)
|
2.62B
est: 2.55B (+2.7%)
|
2.88B
est: 2.76B (+4.2%)
|
2.78B
est: 2.92B (-4.9%)
|
2.87B
est: 3.01B (-4.6%)
|
3.03B
est: 3.35B (-9.5%)
|
3.19B
est: 3.70B (-13.9%)
|
| EPS |
57.42
est: 58.05 (-1.1%)
|
69.63
est: 67.45 (+3.2%)
|
64.68
est: 72.35 (-10.6%)
|
93.66
est: 78.50 (+19.3%)
|
130.01
est: 82.80 (+57.0%)
|
110.33
est: 137.80 (-19.9%)
|
127.56
est: 144.30 (-11.6%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-21 | A | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 4/5 |
| 2026-05-20 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-19 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-18 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-15 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-14 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-13 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-12 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-11 | A+ | 4/5 | 5/5 | 4/5 | 5/5 | 3/5 | 3/5 | 4/5 |
| 2026-05-08 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-07 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-05-01 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-30 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-28 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 4/5 |
| 2026-04-27 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-24 | A | 4/5 | 5/5 | 4/5 | 5/5 | 2/5 | 3/5 | 3/5 |
| 2026-04-23 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-22 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-21 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-20 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-17 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
| 2026-04-16 | A- | 4/5 | 5/5 | 4/5 | 5/5 | 1/5 | 3/5 | 3/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Avantis International Small Cap Equity ETF AVDS | 0.01% | 23.2K | 0.30% |
| 2 | Dimensional - International Small Cap ETF DFIS | 0.00% | 150.7K | 0.39% |
| 3 | iShares Core TOPIX ETF 1475.T | 0.00% | 413.4K | 0.05% |
| 4 | Dimensional - International Core Equity 2 ETF DFIC | 0.00% | 73.5K | 0.22% |
| 5 | Dimensional - International Core Equity Market ETF DFAI | 0.00% | — | 0.18% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Akihiko Fujimoto | President, Head of Sales Division & Representative Director | — | male |
| Mamoru Uchida | Manager of 2nd Research Department and Director | — | male |
| Shoya Iuchi | MD & Chief Technology Officer | — | male |
| Yutaka Tanida | Senior MD, GM of Production & Shiga Plant Manager & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 4462.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
